Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors
Completed · Not applicable
Conditions studied: Osteoporosis, Osteopenia
In brief
The study seeks to determine the impact of assessing risk for osteoporosis in women on patient and physician behaviors through a pharmacist directed osteoporosis screening program. Women will be offered a heel ultrasound to screen for their bone density and may or may not be asked questions about their risk for bone fracture. Pharmacists will counsel and educate all women on ways to prevent the onset of osteoporosis. Women will be telephoned three months after the screening and asked a series of 10 questions to follow up on decisions made by their physicians or changes made to their health behaviors related to bone health.
Key facts
- Study ID
- NCT01572766
- Run by
- Duquesne University
- People needed
- 90
- Starts
- 2010-02-01
- Expected to finish
- 2011-02-01
- Last updated by the study team
- 2012-04-06
Who can join
Age: 45 and older, up to 65. Sex: female. Healthy volunteers: accepted.
You may not qualify if…
- Unable to participate in the follow-up survey conducted over the telephone.
- Age less than 45 years or over 65 years.
- Any individual currently taking biphosphonates for osteoporosis treatment.
- After heel ultrasound is conducted, if T-score is greater than -1.0.
- Males
Where it is running
- Duquesne University Center for Pharmacy Care — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.